Bent Ejlertsen

22PUBLICATIONS
125CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsOncology and carcinogenesis not elsewhere classifiedPacific Peoples social determinants of health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 04, 2026
Omission of axillary lymph node dissection in ultrasound-detectable axillary metastases in primary breast cancer treated by upfront surgery: prospective randomized SENOMAC-ULTRA non-inferiority trial.

|Jul 21, 2025
Association between low-dose aspirin use and breast cancer recurrence: a Danish nationwide cohort study with up to 23 years of follow-up.

Elisabeth Solmunde, Rikke N Pedersen, Mette Nørgaard

|May 23, 2025
Timely germline BRCA testing after invasive breast cancer promotes contralateral risk-reducing mastectomy and improves survival: an observational retrospective study.

Aleksandar M Kostov, Maj-Britt Jensen, Bent Ejlertsen

|Apr 22, 2025
Statin Therapy in Early Breast Cancer: The MASTER Trial; A Randomized Phase III, Placebo-Controlled Comparison of Standard (Neo)Adjuvant Therapy Plus Atorvastatin versus Standard (Neo)Adjuvant Therapy Plus Placebo.

Signe Borgquist, Maj-Britt Jensen, Cecilie Linea Bendorff

|Mar 11, 2025
Prosigna Risk of Recurrence score and intrinsic subtypes are associated with adjuvant anthracycline chemotherapy benefit in high-risk breast cancer.

Maj-Britt Jensen, Torsten O Nielsen, John Bartlett

|Jan 29, 2025
Germline BRCA testing in Denmark following invasive breast cancer: Progress since 2000.

Aleksandar M Kostov, Maj-Britt Jensen, Bent Ejlertsen

Pageof 4

Frequent Collaborators

11 joint publications

Maj-Britt Jensen

9 joint publications

Deirdre P Cronin-Fenton

6 joint publications

Peer M Christiansen

3 joint publications

Søren Cold